Alaunos Therapeutics Email Format

Biotechnology ResearchTexas, United States2-10 Employees

Alaunos Therapeutics is a clinical-stage biotechnology company developing immuno-oncology therapies for solid tumors. Its core approach leverages adoptive TCR-T cell therapy and a discovery platform that engineers T cells to target neoantigens arising from tumor mutations. The company aims to deliver tumor-specific killer T cells to patient populations with unmet clinical needs through rapid and cost-effective methods. Based in Houston, Texas, Alaunos operates within the biotechnology research industry and focuses on therapies for solid tumors. In 2026, the company announced a leadership change with the departure of its Senior Vice President of Legal & Administration.

Sign up for free to view info

Company overview Employee directory